These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 4561726)

  • 41. [Trials on the antigenicity, protectivity and encephalitogenicity of the Hempt vaccine and considerations on rabies protective vaccination in Germany].
    Kuwert E
    Arch Hyg Bakteriol; 1967 May; 151(1):130-45. PubMed ID: 4386311
    [No Abstract]   [Full Text] [Related]  

  • 42. Cellular tests for assessing the immunogenicity of rabies vaccines.
    Kiss Z; Tuboly S
    Acta Vet Acad Sci Hung; 1981; 29(4):349-58. PubMed ID: 7053012
    [No Abstract]   [Full Text] [Related]  

  • 43. [Interferon and antirabies vaccination].
    Atanasiu P
    Salud Publica Mex; 1982; 24(2):123-9. PubMed ID: 6180483
    [No Abstract]   [Full Text] [Related]  

  • 44. Immunogenicity of concentrated and purified rabies vaccine of tissue culture origin.
    Wiktor TJ; Sokol F; Kuwert E; Koprowski H
    Proc Soc Exp Biol Med; 1969 Jul; 131(3):799-805. PubMed ID: 5791793
    [No Abstract]   [Full Text] [Related]  

  • 45. [Determination of the degree of antirabies immunity in mice with different capabilities for interferon formation].
    Karakuiumchian MK; Bektemirova MS; Polkovnikova VIa
    Vopr Virusol; 1973; 18(3):275-7. PubMed ID: 4769528
    [No Abstract]   [Full Text] [Related]  

  • 46. A synthetic peptide encompassing the G5 antigenic region of the rabies virus induces high avidity but poorly neutralizing antibody in immunized animals.
    Niederhäuser S; Bruegger D; Zahno ML; Vogt HR; Peterhans E; Zanoni R; Bertoni G
    Vaccine; 2008 Dec; 26(52):6749-53. PubMed ID: 18955098
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Immunology of interferons. II. Heterospecific activities of human interferons and their neutralization by antibody.
    Levy-Koenig RE; Golgher RR; Paucker K
    J Immunol; 1970 Apr; 104(4):791-7. PubMed ID: 4315263
    [No Abstract]   [Full Text] [Related]  

  • 48. [Rapid changes of the pathogenicity for the adult mouse of a special avianized variant of rabies fixed virus of the Sassari strain].
    Rocchi G; Andreoni G
    Nuovi Ann Ig Microbiol; 1968; 19(5):320-5. PubMed ID: 5716646
    [No Abstract]   [Full Text] [Related]  

  • 49. Protective antibody response of Balb/c mice to Bali rabies virus isolate propagated in BHK-21 cells.
    Astawa INM; Agustini NLP; Masa Tenaya IW; Aryawiguna IPGW
    J Vet Med Sci; 2018 Nov; 80(10):1596-1603. PubMed ID: 30210066
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Modified live-virus rabies vaccine produced from flury high egg-passage virus grown on an established canine-kidney cell line: three-year duration-of-immunity study in dogs.
    Brown AL; Merry DL; Beckenhauer WH
    Am J Vet Res; 1973 Nov; 34(11):1427-32. PubMed ID: 4748726
    [No Abstract]   [Full Text] [Related]  

  • 51. Determination of the site of oral rabies vaccination.
    Baer GM; Broderson JR; Yager PA
    Am J Epidemiol; 1975 Feb; 101(2):160-4. PubMed ID: 1124754
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rabies in rabbits and mice: protective effect of polyriboinosinic-polyribocytidylic acid.
    Janis B; Habel K
    J Infect Dis; 1972 Apr; 125(4):345-52. PubMed ID: 4553077
    [No Abstract]   [Full Text] [Related]  

  • 53. Production of an inactivated rabies vaccine in primary dog kidney cells.
    van Wezel AL; van Steenis G
    Dev Biol Stand; 1978; 40():69-75. PubMed ID: 98375
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Properties of rabies strain ("Pasteur Potsdam") adapted to primary dog kidney cells.
    Egert J; Apitzsch L; Triquart B; Sinnecker H
    Acta Virol; 1989 Dec; 33(6):553-8. PubMed ID: 2483605
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Characterization of brain-associated rabies neutralizing substance.
    Gough PM; Dierks RE; Russell RM; Archer BG
    J Infect Dis; 1974 Apr; 129(4):456-60. PubMed ID: 4206247
    [No Abstract]   [Full Text] [Related]  

  • 56. Immune responses of humans to a human diploid cell strain of rabies virus vaccine: lymphocyte transformation, production of virus-neutralizing antibody, and induction of interferon.
    Nicholson KG; Cole PJ; Turner GS; Harrison P
    J Infect Dis; 1979 Aug; 140(2):176-82. PubMed ID: 479638
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Postexposure rabies prophylaxis with human rabies immune globulin.
    Hattwick MA; Rubin RH; Music S; Sikes RK; Smith JS; Gregg MB
    JAMA; 1974 Jan; 227(4):407-10. PubMed ID: 4859675
    [No Abstract]   [Full Text] [Related]  

  • 58. Induction of interferon by bacterial endotoxin.
    Nagano Y; Maehara N
    Methods Enzymol; 1981; 78(Pt A):258-61. PubMed ID: 6173600
    [No Abstract]   [Full Text] [Related]  

  • 59. [Determination of anti-rabies antibodies by means of the indirect immunofluorescence method].
    Jiran E; Závora M
    Vet Med (Praha); 1975 Jun; 20(7):363-71. PubMed ID: 810938
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Engineering of a recombinant trivalent single-chain variable fragment antibody directed against rabies virus glycoprotein G with improved neutralizing potency.
    Turki I; Hammami A; Kharmachi H; Mousli M
    Mol Immunol; 2014 Feb; 57(2):66-73. PubMed ID: 24091293
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.